de Filippis, R. and Al Foysal, A. (2024) Case Report: The Role of Monoamine Oxidase Inhibitors in Treating Resistant Depression. Open Access Library Journal, 11, 1-12. doi: 10.4236/oalib.1112369 .

Dr Miriam Stoppard shares surprising research from Oxford University that shows why antidepressants that change serotonin ...

“The condition is commonly associated with the use of certain medications, particularly those that enhance serotonin activity, such as selective serotonin reuptake inhibitors (SSRIs), ...

Variants of the PER3 gene disrupt adrenal adaptation to winter light, leading to serotonin disruption and depression-like ...

Today, doctors have many alternative medication choices with little or no addictive potential. The treatment of choice for ...

College students have opportunities to bend or break the rules after leaving home. It can be dangerous for those who take ...

In patients with PAH, reducing peripheral serotonin using rodatristat ethyl negatively affects pulmonary hemodynamics and cardiac function.

High-dose centanafadine was well-tolerated and outperformed placebo in improving ADHD symptoms among children and adolescents with ADHD.

Also known as selective COX-2 inhibitors, these medications treat inflammatory pain. Selective COX-2 inhibitors are a type of nonsteroidal anti-inflammatory medication (also known as NSAIDs).

The inhibitors bind to the catalytic zinc ion within the enzyme cavity. Several such derivatives are clinically used inhibitors, such as acetazolamide, methazolamide, ethoxzolamide ...

Savella (milnacipran) is another common SNRI and is used to manage fibromyalgia. Selective serotonin reuptake inhibitors (SSRIs) and SNRIs are both antidepressants but work differently. SSRIs work by ...

Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) are two of the most common types of medications used to treat conditions such as depression, ...